Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    2460463 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Vaccine Treatment for Advanced Non-Small Cell Lung Cancer
Conditions: Non-small Cell Carcinoma;   Adenocarcinoma of Lung;   Squamous Cell Carcinoma;   Large Cell Carcinoma;   Lung Neoplasms
Intervention: Biological: Drug: Hyperacute Lung Cancer Cell Vaccine

Indicates status has not been verified in more than two years